9JIM
Rat hepatitis E virus capsid protein E2s domain in complex with Fab C145
Summary for 9JIM
Entry DOI | 10.2210/pdb9jim/pdb |
EMDB information | 61510 |
Descriptor | Pro-secreted protein ORF2, C145 Fab light chain, C145 Fab heavy chain (3 entities in total) |
Functional Keywords | hepatitis e virus, capsid protein, e2s domain, immune complex, c145 antibody, viral protein/immune system, viral protein-immune system complex |
Biological source | Rocahepevirus ratti More |
Total number of polymer chains | 6 |
Total formula weight | 99193.58 |
Authors | |
Primary citation | Chen, Z.,Liu, L.,Situ, J.,Li, G.,Guo, S.,Lai, Q.,Wu, S.,Jiang, Y.,Fan, J.,Tang, Z.,Li, Y.,Wen, G.,Wang, S.,Ying, D.,Liang, Y.,Siu-Fung Ho, S.,Ma, X.,Yiu-Hung Tsoi, J.,Hon-Kiu Shun, E.,Foo-Siong Chew, N.,Ma, W.,Mao, W.,Li, T.,Chen, Z.,Fang, M.,Wang, Y.,Yu, H.,Zhang, F.,Zhang, A.J.,Li, S.,Xia, N.,Sridhar, S.,Zheng, Q.,Zheng, Z. Antibodies elicited by hepatitis E vaccination in humans confer cross-genus protection against rat hepatitis E virus. J Hepatol, 2025 Cited by PubMed Abstract: Paslahepevirus balayani (bHEV), also known as hepatitis E virus (HEV), encompasses eight genotypes, five of which infect humans. Rats are natural reservoirs of Rocahepevirus ratti genotype 1 (HEV-r-1; rat HEV; rHEV), which has recently been implicated in viral hepatitis. Despite the antigenic divergence between bHEV and rHEV, studies on shared protective antibodies remain rare. PubMed: 40571163DOI: 10.1016/j.jhep.2025.06.015 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (2.86 Å) |
Structure validation
Download full validation report
